JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Enzymatic Synthesis of 1, 2-Hexanediol Galactoside by Whole Cells of β-Galactosidase-containing Recombinant Escherichia coli
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : Journal of Life Science
  • Volume 26, Issue 5,  2016, pp.608-613
  • Publisher : Korean Society of Life Science
  • DOI : 10.5352/JLS.2016.26.5.608
 Title & Authors
Enzymatic Synthesis of 1, 2-Hexanediol Galactoside by Whole Cells of β-Galactosidase-containing Recombinant Escherichia coli
Kim, Yi-Ok; Jung, Kyung-Hwan;
  PDF(new window)
 Abstract
Recently, it has been reported that some preservatives used in cosmetics lead to skin problems. Among the many cosmetic ingredients, 1, 2-hexanediol (HD) is used as both a preservative and humectant. In order to develop safer ingredients, we studied the synthesis of 1, 2-hexanediol galactoside (HD-G) by a transgalactosylation reaction using β-galactosidase (β-gal)-containing recombinant Escherichia coli cells. The transgalactosylation reaction was carried out under high-lactose conditions for 24 hr. After 12 hr had elapsed, a new spot was identified by thin-layer chromatography (TLC) analysis, and we presumptively designated this new spot as HD-G. Then, we carried out the purification of the presumptive HD-G spot from the reaction mixture by using silica gel chromatography, and its mass was measured by electrospray ionization-mass spectrometry. The purified new spot on the chromatograph was identified a sodium adduct ion ([M+Na]+, m/z
 Keywords
1, 2-Hexanediol;β-Galactosidase;cosmetic preservative;Escherichia coli;transgalactosylation;
 Language
Korean
 Cited by
 References
1.
Bridiau, N., Taboubi, S., Marzouki, N., Legoy, M. D. and Maugard, T. 2006. β-Galactosidase catalyzed selective galactosylation of aromatic compounds. Biotechnol. Prog. 22, 326-330. crossref(new window)

2.
Davis, B. G. and Robinson, M. A. 2002. Drug delivery systems based on sugar-macromolecule conjugates. Curr. Opin. Drug Discov. Devel. 5, 279-288.

3.
Herman, A., Herman, A. P., Domagalska, B. W. and Młynarczyk, A. 2013. Essential oils and herbal extracts as antimicrobial agents in cosmetic emulsion. Indian J. Microbiol. 53, 232-237. crossref(new window)

4.
Huang, J., Gao, F., Tang, X., Yu, J., Wang, D., Liu, S. and Li, Y. 2010. Liver-targeting doxorubicin-conjugated polymeric prodrug with pH-triggered drug release profile. Polym. Int. 59, 1390-1396. crossref(new window)

5.
Johnson, W. Jr., Bergfeld, W. F., Belsito, D. V., Hill, R. A., Klaassen, C. D., Liebler, D., Marks, J. G. Jr., Shank, R. C., Slaga, T. J., Snyder, P. W. and Andersen, F. A. 2012. Safety assessment of 1,2-glycols as used in cosmetics. Int. J. Toxicol. 31(5 Suppl), 147S-168S. crossref(new window)

6.
Jung, K. H. 2008. Enhanced enzyme activities of inclusion bodies of recombinant β-galactosidase via the addition of inducer analog after L-arabinose induction in the araBAD promoter system of Escherichia coli. J. Microbiol. Biotechnol.18, 434-442.

7.
Jung, K. H. and Lee, H. Y. 2015. Escherichia coli β-galactosidase-catalyzed synthesis of 2-phenoxyethanol galactoside and its characterization. Bioprocess Biosyst. Eng. 38, 365-372. crossref(new window)

8.
Jung, K. H., Yeon, J. H., Moon, S. K. and Choi, J. H. 2008. Methyl α-D-glucopyranoside enhances the enzymatic activity of recombinant β-galactosidase inclusion bodies in the araBAD promoter system of Escherichia coli. J. Ind. Microbiol. Biotechnol. 35, 695-701. crossref(new window)

9.
Lee, E., An, S., Cho, S. A., Yun, Y., Han, J., Hwang, Y. K., Kim, H. K. and Lee, T. R. 2011. The influence of alkane chain length on the skin irritation potential of 1,2-alkanediols. Int. J. Cosmet. Sci. 33, 421-425. crossref(new window)

10.
Lee, J. Y., Lee J. N., Lee, G. T. and Lee, K. K. 2012. Development of antimicrobial plant extracts and its application to cosmetics. J. Soc. Cosmet. Scientists Korea 38, 171-179. crossref(new window)

11.
Lee, S. E., Jo, T. M., Lee, H. Y., Lee, J. and Jung, K. H. 2013. β-Galactosidase-catalyzed synthesis of galactosyl chlorphenesin and its characterization. Appl. Biochem. Biotechnol. 171, 1299-1312. crossref(new window)

12.
Melisi, D., Curcio, A., Luongo, E., Morelli, E. and Rimoli, M. G. 2011. D-Galactose as a vector for prodrug design. Curr. Top. Med. Chem. 11, 2288-2298. crossref(new window)

13.
Scheckermann, C., Wagner, F. and Fischer, L. 1997. Galactosylation of antibiotics using the β-galactosidase from Aspergillus oryae. Enzyme Microb. Technol. 20, 629-634. crossref(new window)

14.
Sanchez-Prado, L., Alvarez-Rivera, G., Lamas, J. P., Llompart, M., Loresa, M. and Garcia-Jares, C. 2013. Content of suspected allergens and preservatives in marketed baby and child care products. Anal. Methods 5, 416-427. crossref(new window)

15.
Siti-Zulaikha, R., Sharifah-Norkhadijah, S. I. and Praveena, S. M. 2015. Hazardous ingredients in cosmetics and personal care products and health concern: A review. Public Health Res. 5, 7-15.

16.
Tietze, L. F. and Schmuck, K. 2011. Prodrugs for targeted tumor therapies: recent developments in ADEPT, GDEPT and PMT. Curr. Pharm. Des. 17, 3527-3547. crossref(new window)